Diuretic Drugs Market size to grow by USD 95.64 million from 2021 to 2026, Driven by the increasing incidence of hypertension among people - Technavio

NEW YORK, April 12, 2023 /PRNewswire/ -- The diuretic drugs market size is forecasted to increase by USD 95.64 million from 2021 to 2026, at a CAGR of 5.44%, according to the recent market study by Technavio. The growth of the market will be driven by the increasing incidence of hypertension among people, rising drug distribution through online channels, and the growing geriatric population. Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. View a Sample Report. 

Diuretic Drugs Market - Vendor Analysis:

The global diuretic drugs market is fragmented, with various types of branded drugs and generics of some loop and thiazide diuretic drugs. Technavio has extensively analyzed 15 major vendors, including AbbVie Inc., Akorn Inc., Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aurobindo Pharma Ltd., Bausch Health Companies Inc., Casper Pharma, Hikma Pharmaceuticals Plc, Lannett Co. Inc., Monarch Pharmachem, Novartis AG, Padagis US LLC, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Validus Pharmaceuticals LLC, VITARIS AG, and Zydus Lifesciences Ltd.

Get a holistic overview of the market by industry experts to evaluate and develop growth
strategies. Download the Sample

Vendor Offerings -

• AbbVie Inc. - The company offers diuretic drugs such as Microzide.
• Alembic Pharmaceuticals Ltd. - The company offers diuretic drugs such as Valembic H.
• Aurobindo Pharma Ltd. - The company offers diuretic drugs such as Torsemide.

Key Benefits for Industry Players & Stakeholders – 

• The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
• It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.
• The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Expand operations in the future - To get requisite details, ask for a custom report.

Diuretic Drugs Market - Market Segmentation:

The report extensively covers diuretic drugs market segmentation by product type (loop diuretics, thiazide diuretics, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)).

• The market share growth in the loop diuretic drugs segment will be significant for the market growth during the forecast period. Loop diuretic drugs are widely used to treat high blood pressure and edema, which are often caused due to chronic kidney disease (CKD) or congestive heart failure. Furosemide, bumetanide, and torasemide are some of the loop diuretic drugs. Diuretic drugs have greater bioavailability, a longer half-life, and higher potency than other diuretic drugs available in the market. Hence, it is anticipated that the loop diuretic drugs segment will witness high growth during the forecast period.

Charts & data tables about market and segment sizes for the forecast period (2022-
2026) have been covered in this report. Download the Sample Report

Diuretic Drugs Market - Market Dynamics:

Key Drivers:

• A key factor driving the diuretic drugs market is the increasing incidence of hypertension due to the rising pressure on the walls of the arteries.
• The risk of diseases such as stroke, kidney failure, and heart disease increases due to hypertension. It can also affect the brain by causing a TIA, stroke, dementia, or mild cognitive impairment.
• The majority of hypertension prevalence is in low- and middle-income countries, and complications of hypertension result in approximately 55% of cardiovascular-related deaths each year.
• Hypertension is a silent killer, and it often has no warning signs or symptoms. It can also cause problems such as sexual dysfunction, bone loss, and conditions such as obstructive sleep apnea (OSA).
• Hence, the increase in the number of patients with hypertension owing to diabetes, obesity, the occurrence of CKD, a sedentary lifestyle, stress, and alcohol addiction will drive the growth of the market during the forecast period.

Major Trends:

• The rising incidence of kidney diseases is one of the key trends that is expected to impact the market positively during the forecast period.
• The leading causes for the increasing prevalence of CKD are the increased number of diabetes cases, high blood pressure, heart disease, and people with a family history of kidney disease.
• Approximately 10% of the population worldwide is affected by CKD, and millions die each year due to the lack of access to affordable treatment.
• For instance, in the US, 15% of adults, or 37 million people, are estimated to have kidney disease. Similarly, the strong prevalence of CKD is significantly attributed to the prevalence of edema.
• Hence, such an increasing prevalence of kidney diseases is driving the growth of the global diuretic drugs market during the forecast years.

Key Challenges:

• A main challenge hampering the growth of the diuretic drugs market is the price pressure and availability of counterfeited drugs.
• Global vendors reduce the cost of their products to increase sales and obtain low-cost sales agreements. However, vendors make significant investments in marketing, promoting, and improving their brands to gain a competitive edge, as intense competition among the players causes price wars.
• Regional or local vendors offer products at low costs compared with the global players, allowing consumers to select from a wide range of products.
• Customers in developing countries have low awareness of diuretic drugs and low purchasing power, which leads to a decrease in profit margins and an overall decline in revenue.
• Hence, the pricing pressure may hinder the growth of the drug market during the forecast period.

To get detailed insights about drivers, trends, and challenges, buy the report 

What are the key data covered in this diuretic drugs market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the diuretic drugs market between 2022 and 2026
• Precise estimation of the size of the diuretic drugs market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the diuretic drugs market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of diuretic drugs market vendors

Gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform 

Related Reports:

• The narcolepsy drugs market size is expected to increase by USD 1.60 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.1%. This report extensively covers narcolepsy drugs market segmentation by type (narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary narcolepsy) and geography (North America, Europe, Asia, and Rest of World (ROW)). The rising product launches and clinical trials are notably driving the narcolepsy drugs market growth.
• The darier disease drugs market size is expected to increase to USD 45.37 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.6%. This report extensively covers market segmentation by product (topical retinoids, oral retinoids, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The increase in demand for advanced dermatological diagnosis is notably driving the darier disease drugs market growth.

Browse for Technavio's Health Care Market Reports 

Key Topics Covered:

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Product Type
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis 
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026 
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers 
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers 
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants 
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes 
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product Type

• 5.1 Market segments
• Exhibit 24: Chart on Product Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Product Type - Market share 2021-2026 (%)

• 5.2 Comparison by Product Type 
• Exhibit 26: Chart on Comparison by Product Type
• Exhibit 27: Data Table on Comparison by Product Type

• 5.3 Loop diuretics - Market size and forecast 2021-2026 
• Exhibit 28: Chart on Loop diuretics - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Loop diuretics - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Loop diuretics - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Loop diuretics - Year-over-year growth 2021-2026 (%)

• 5.4 Thiazide diuretics - Market size and forecast 2021-2026 
• Exhibit 32: Chart on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Thiazide diuretics - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Thiazide diuretics - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Thiazide diuretics - Year-over-year growth 2021-2026 (%)

• 5.5 Others - Market size and forecast 2021-2026 
• Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.6 Market opportunity by Product Type 
• Exhibit 40: Market opportunity by Product Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview 
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation 
• Exhibit 42: Chart on Market share by geography 2021-2026 (%)
• Exhibit 43: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison 
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026 
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026 
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026 
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026 
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026 
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 Denmark - Market size and forecast 2021-2026 
• Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)

• 7.9 China - Market size and forecast 2021-2026 
• Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)

• 7.10 Canada - Market size and forecast 2021-2026 
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.11 India - Market size and forecast 2021-2026 
• Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography 
• Exhibit 82: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges 
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered

• 10.2 Market positioning of vendors 
• Exhibit 88: Matrix on vendor position and classification

• 10.3 AbbVie Inc.
• Exhibit 89: AbbVie Inc. - Overview
• Exhibit 90: AbbVie Inc. - Product / Service
• Exhibit 91: AbbVie Inc. - Key offerings

• 10.4 Alembic Pharmaceuticals Ltd. 
• Exhibit 92: Alembic Pharmaceuticals Ltd. - Overview
• Exhibit 93: Alembic Pharmaceuticals Ltd. - Product / Service
• Exhibit 94: Alembic Pharmaceuticals Ltd. - Key offerings

• 10.5 Aurobindo Pharma Ltd. 
• Exhibit 95: Aurobindo Pharma Ltd. - Overview
• Exhibit 96: Aurobindo Pharma Ltd. - Product / Service
• Exhibit 97: Aurobindo Pharma Ltd. - Key offerings

• 10.6 Hikma Pharmaceuticals Plc 
• Exhibit 98: Hikma Pharmaceuticals Plc - Overview
• Exhibit 99: Hikma Pharmaceuticals Plc - Business segments
• Exhibit 100: Hikma Pharmaceuticals Plc - Key offerings
• Exhibit 101: Hikma Pharmaceuticals Plc - Segment focus

• 10.7 Novartis AG
• Exhibit 102: Novartis AG - Overview
• Exhibit 103: Novartis AG - Business segments
• Exhibit 104: Novartis AG - Key offerings
• Exhibit 105: Novartis AG - Segment focus

• 10.8 Pfizer Inc.
• Exhibit 106: Pfizer Inc. - Overview
• Exhibit 107: Pfizer Inc. - Product / Service
• Exhibit 108: Pfizer Inc. - Key news
• Exhibit 109: Pfizer Inc. - Key offerings

• 10.9 Sun Pharmaceutical Industries Ltd. 
• Exhibit 110: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 111: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 112: Sun Pharmaceutical Industries Ltd. - Key offerings

• 10.10 Teva Pharmaceutical Industries Ltd. 
• Exhibit 113: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 114: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 115: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 116: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 117: Teva Pharmaceutical Industries Ltd. - Segment focus

• 10.11 Validus Pharmaceuticals LLC 
• Exhibit 118: Validus Pharmaceuticals LLC - Overview
• Exhibit 119: Validus Pharmaceuticals LLC - Product / Service
• Exhibit 120: Validus Pharmaceuticals LLC - Key offerings

• 10.12 VITARIS AG
• Exhibit 121: VITARIS AG - Overview
• Exhibit 122: VITARIS AG - Product / Service
• Exhibit 123: VITARIS AG - Key offerings

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist 
• Exhibit 124: Inclusions checklist
• Exhibit 125: Exclusions checklist

• 11.3 Currency conversion rates for US$ 
• Exhibit 126: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 127: Research methodology
• Exhibit 128: Validation techniques employed for market sizing
• Exhibit 129: Information sources

• 11.5 List of abbreviations 
• Exhibit 130: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio